RTI Surgical (RTIX) Upgraded to “Sell” by BidaskClub

BidaskClub upgraded shares of RTI Surgical (NASDAQ:RTIX) from a strong sell rating to a sell rating in a research note released on Saturday.

Separately, Zacks Investment Research upgraded RTI Surgical from a sell rating to a hold rating in a research note on Friday, October 13th.

Shares of RTI Surgical (RTIX) opened at $4.40 on Friday. RTI Surgical has a 52 week low of $3.01 and a 52 week high of $6.00. The company has a current ratio of 3.34, a quick ratio of 1.21 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $261.84, a P/E ratio of -62.86, a price-to-earnings-growth ratio of 1.98 and a beta of 1.76.

RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The company had revenue of $66.69 million during the quarter, compared to analyst estimates of $65.63 million. RTI Surgical’s revenue for the quarter was up .2% on a year-over-year basis. equities analysts anticipate that RTI Surgical will post 0.05 earnings per share for the current year.

Large investors have recently bought and sold shares of the business. Prudential Financial Inc. purchased a new stake in RTI Surgical during the 3rd quarter worth approximately $111,000. Citadel Advisors LLC increased its stake in RTI Surgical by 85.7% during the 3rd quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock worth $122,000 after buying an additional 12,361 shares in the last quarter. Citigroup Inc. increased its stake in RTI Surgical by 2,850.1% during the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 20,435 shares in the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in RTI Surgical during the 3rd quarter worth approximately $144,000. Finally, Thompson Davis & CO. Inc. increased its stake in RTI Surgical by 138.8% during the 2nd quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock worth $147,000 after buying an additional 14,577 shares in the last quarter. Institutional investors own 69.90% of the company’s stock.

WARNING: This article was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.com-unik.info/2018/01/10/rti-surgical-rtix-upgraded-to-sell-by-bidaskclub.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

What are top analysts saying about RTI Surgical? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RTI Surgical and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit